Your browser doesn't support javascript.
loading
Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results.
Smolen, Josef S; Choe, Jung-Yoon; Prodanovic, Nenad; Niebrzydowski, Jaroslaw; Staykov, Ivan; Dokoupilova, Eva; Baranauskaite, Asta; Yatsyshyn, Roman; Mekic, Mevludin; Porawska, Wieskawa; Ciferska, Hana; Jedrychowicz-Rosiak, Krystyna; Zielinska, Agnieszka; Choi, Jasmine; Rho, Young Hee.
Afiliación
  • Smolen JS; Division of Rheumatology, Department of Medicine, Medical University of Vienna, Vienna, Austria.
  • Choe JY; Division of Rheumatology, Daegu Catholic University Medical Center, Daegu, South Korea.
  • Prodanovic N; Department of Rheumatology and Clinical Immunology, Clinical Center Banja Luka, Banja Luka, Bosnia and Herzegovina.
  • Niebrzydowski J; Divison of Rheumatology, Medica Pro Familia, Gdynia, Poland.
  • Staykov I; Divison of Rheumatology, MHAT "Dr. Ivan Seliminski", Sliven, AD, Bulgaria.
  • Dokoupilova E; Divison of Rheumatology, MEDICAL PLUS s.r.o, Uherske Hradiste, Czech Republic.
  • Baranauskaite A; Division of Rheumatology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Yatsyshyn R; Division of Rheumatology, SHEI Ivano-Frankivsk NMU, Ivano-Frankivsk, Ukraine.
  • Mekic M; Department of Health, Diseases and Rheumatism, University Clinic Centre Sarajevo, Sarajevo, Bosnia and Herzegovina.
  • Porawska W; Division of Rheumatology, Poznanski Osrodek Medyczny NOVAMED, Poznan, Poland.
  • Ciferska H; Division of Rheumatology, Revmatologicky ustav, Praha, Czech Republic.
  • Jedrychowicz-Rosiak K; Divison of Rheumatology, MCBK S.C., Grodzisk Mazowiecki.
  • Zielinska A; Divison of Rheumatology, Medica Pro Familia, Warszawa, Poland.
  • Choi J; Samsung Bioepis, Incheon, South Korea.
  • Rho YH; Samsung Bioepis, Incheon, South Korea.
Rheumatology (Oxford) ; 56(10): 1771-1779, 2017 10 01.
Article en En | MEDLINE | ID: mdl-28957563

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos / Biosimilares Farmacéuticos / Infliximab Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos / Biosimilares Farmacéuticos / Infliximab Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Austria